| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Abbvie Inc. (ABBV) has 5 insiders with recent SEC Form 4 filings, including 0 buys and 24 sells. ABBV is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| VP | 177.3K | $38.38M | - | |
| VP | 68.3K | $14.79M | - | |
| Dir | 28.5K | $6.17M | - | |
| Dir | 10.3K | $2.22M | - | |
| Dir | 707 | $153.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 4, 2017 | Alban Carlos | EVP, Commercial Operations | Sell | 43,000 | $67.00 | $2,881,000.00 | -27.3% | |
| Mar 28, 2017 | Abbvie Inc. | 10% Owner | Sell | 450,000 | $22.50 | $10,125,000.00 | -27.4% | |
| Mar 10, 2017 | Michael Robert A. | VP, Controller | Sell | 5,132 | $65.29 | $335,068.28 | -23.5% | |
| Mar 10, 2017 | Schumacher Laura J | Executive Vice President | Sell | 40,000 | $65.26 | $2,610,256.69 | -2.3% | |
| Mar 10, 2017 | Richmond Timothy J.47 | SVP, Human Resources | Sell | 22,451 | $65.29 | $1,465,825.79 | -46.3% | |
| Mar 8, 2017 | Gonzalez Richard A45 | Chairman Of The Board And CEO | Sale+OE | 72,016 | $64.25 | $4,627,028.00 | -17.0% | |
| Feb 28, 2017 | Hurwich Thomas A. | VP, Controller | Sell | 2,311 | $61.89 | $143,030.70 | -1.1% | |
| Dec 2, 2016 | Chase William J | EVP, Chief Financial Officer | Sale+OE | 6,600 | $59.19 | $390,654.00 | -3.7% | |
| Nov 16, 2016 | Hurwich Thomas A. | VP, Controller | Sale+OE | 3,100 | $62.00 | $192,200.00 | -4.8% | |
| Sep 7, 2016 | Schumacher Laura J | Executive Vice President | Sell | 50,000 | $65.00 | $3,250,000.00 | -25.8% |